We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-1.82%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.62B
AUM Growth
-$78.2M
Cap. Flow
+$170M
Cap. Flow %
2.57%
Top 10 Hldgs %
19.73%
Holding
1,693
New
145
Increased
789
Reduced
545
Closed
129

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$16.2M
2
T icon
AT&T
T
+$11.1M
3
MPLX icon
MPLX
MPLX
+$8.39M
4
MSFT icon
Microsoft
MSFT
+$4.77M
5
MS icon
Morgan Stanley
MS
+$4.66M

Sector Composition

Rank Sector Weight
1 Technology 19.28%
2 Financials 11.18%
3 Industrials 7.8%
4 Healthcare 7.65%
5 Consumer Discretionary 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENB icon
76
Enbridge
ENB
$121B
$16.6M 0.25%
374,812
-11,452
-3% -$498K
PFE icon
77
Pfizer
PFE
$142B
$16.1M 0.24%
636,215
+54,844
+9% +$1.44M
ZTS icon
78
Zoetis
ZTS
$31.9B
$15.5M 0.23%
94,346
+1,232
+1% +$205K
EPD icon
79
Enterprise Products Partners
EPD
$82.5B
$15.3M 0.23%
449,091
+792
+0.2% +$26.4K
AXP icon
80
American Express
AXP
$228B
$15.3M 0.23%
56,909
+6,900
+14% +$2.04M
LMT icon
81
Lockheed Martin
LMT
$132B
$15.2M 0.23%
34,026
+2,339
+7% +$1.08M
KMX icon
82
CarMax
KMX
$8.33B
$15.2M 0.23%
194,872
-4,939
-2% -$396K
TMO icon
83
Thermo Fisher Scientific
TMO
$214B
$15.1M 0.23%
30,272
+814
+3% +$441K
SCHD icon
84
Schwab US Dividend Equity ETF
SCHD
$103B
$15.1M 0.23%
538,426
+77,616
+17% +$2.16M
HON icon
85
Honeywell
HON
$76.7B
$15M 0.23%
75,306
+8,343
+12% +$1.69M
BMY icon
86
Bristol-Myers Squibb
BMY
$132B
$14.8M 0.22%
242,509
+27,289
+13% +$1.59M
CRWD icon
87
CrowdStrike
CRWD
$189B
$14.5M 0.22%
164,744
+15,652
+10% +$1.49M
VST icon
88
Vistra
VST
$50.1B
$14.5M 0.22%
123,521
+29,537
+31% +$4.41M
CRM icon
89
Salesforce
CRM
$148B
$14.3M 0.22%
53,137
+2,958
+6% +$920K
ROK icon
90
Rockwell Automation
ROK
$52.4B
$14.2M 0.21%
55,083
-200
-0.4% -$55.7K
SMCI icon
91
Super Micro Computer
SMCI
$17.9B
$14.2M 0.21%
415,230
+29,678
+8% +$1.13M
FTCS icon
92
First Trust Capital Strength ETF
FTCS
$7.95B
$14.2M 0.21%
158,085
+3,821
+2% +$341K
AMAT icon
93
Applied Materials
AMAT
$398B
$14.2M 0.21%
97,520
+24,928
+34% +$4.19M
JEF icon
94
Jefferies Financial Group
JEF
$12.7B
$14.1M 0.21%
264,074
-14,004
-5% -$951K
BUFR icon
95
FT Vest Fund of Buffer ETFs
BUFR
$10.1B
$14.1M 0.21%
473,884
+75,639
+19% +$2.31M
AFL icon
96
Aflac
AFL
$64.8B
$14M 0.21%
126,321
-2,247
-2% -$238K
ABT icon
97
Abbott
ABT
$183B
$14M 0.21%
105,363
+4,694
+5% +$597K
LQD icon
98
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$13.9M 0.21%
127,948
+9,551
+8% +$1.03M
XLV icon
99
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$13.8M 0.21%
94,757
+9,185
+11% +$1.33M
PM icon
100
Philip Morris
PM
$299B
$13.7M 0.21%
86,388
+3,919
+5% +$555K

Similar funds

Oppenheimer & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Oppenheimer & Co held 1,693 positions worth $6.62B, down 1.2% from $6.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Oppenheimer & Co's Q1 2025 filing shows 145 new, 789 increased, 545 reduced and 129 closed positions. Its largest new stake was PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund: 105,496 shares worth $7.56M. The largest sale was Palantir, an estimated $16.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q1 2025 buy was PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund: 105,496 shares worth $7.56M.
  • Oppenheimer & Co added most to Vodafone in Q1 2025, an estimated $14.5M increase.
  • Oppenheimer & Co's biggest Q1 2025 reduction was Palantir, cutting an estimated $16.2M.
  • Oppenheimer & Co fully exited Astera Labs in Q1 2025, selling an estimated $3.48M.
  • Oppenheimer & Co's ten largest holdings make up 20% of its $6.62B portfolio in Q1 2025.
  • Oppenheimer & Co opened 145 new positions and closed 129 in Q1 2025.
  • Oppenheimer & Co's portfolio value fell 1.2% quarter-over-quarter to $6.62B.

Based on Oppenheimer & Co's 13F filing for Q1 2025, filed 23 Apr 2025.